Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2017 | 694 | 0.96 | Why? |
| Expert Systems | 1 | 2021 | 42 | 0.88 | Why? |
| Violence | 2 | 2017 | 534 | 0.86 | Why? |
| Data Curation | 1 | 2021 | 144 | 0.82 | Why? |
| Data Mining | 3 | 2018 | 767 | 0.67 | Why? |
| Medical Informatics Applications | 1 | 2018 | 111 | 0.65 | Why? |
| Machine Learning | 7 | 2021 | 4395 | 0.63 | Why? |
| Firearms | 2 | 2017 | 238 | 0.62 | Why? |
| Hypercholesterolemia | 1 | 2017 | 175 | 0.59 | Why? |
| Wounds, Gunshot | 1 | 2017 | 248 | 0.50 | Why? |
| Pharmacovigilance | 1 | 2017 | 501 | 0.50 | Why? |
| Ischemic Attack, Transient | 1 | 2017 | 439 | 0.50 | Why? |
| Health Planning | 1 | 2020 | 607 | 0.49 | Why? |
| Research Support as Topic | 1 | 2017 | 327 | 0.48 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.47 | Why? |
| Electronic Health Records | 10 | 2021 | 3492 | 0.46 | Why? |
| Social Networking | 1 | 2018 | 737 | 0.44 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.35 | Why? |
| Decision Making | 3 | 2018 | 3132 | 0.33 | Why? |
| Publishing | 1 | 2017 | 990 | 0.32 | Why? |
| Patient Care Management | 1 | 2018 | 1514 | 0.31 | Why? |
| Cause of Death | 2 | 2017 | 4823 | 0.31 | Why? |
| Evidence-Based Medicine | 2 | 2018 | 3228 | 0.30 | Why? |
| Vocabulary, Controlled | 2 | 2016 | 26 | 0.29 | Why? |
| Referral and Consultation | 2 | 2018 | 4816 | 0.28 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.28 | Why? |
| Phenotype | 1 | 2016 | 4037 | 0.28 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.28 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.27 | Why? |
| Molecular Sequence Annotation | 2 | 2018 | 478 | 0.26 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.26 | Why? |
| Decision Support Systems, Clinical | 2 | 2019 | 551 | 0.25 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.25 | Why? |
| Cardiovascular Diseases | 2 | 2018 | 11497 | 0.25 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.24 | Why? |
| Models, Statistical | 2 | 2020 | 5312 | 0.24 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.23 | Why? |
| Skin Diseases | 1 | 2018 | 2509 | 0.22 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2018 | 6166 | 0.21 | Why? |
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2018 | 22 | 0.19 | Why? |
| Piracetam | 1 | 2017 | 6 | 0.18 | Why? |
| Decision Making, Computer-Assisted | 1 | 2018 | 61 | 0.18 | Why? |
| Phenytoin | 1 | 2017 | 17 | 0.18 | Why? |
| Chemotherapy, Adjuvant | 1 | 2021 | 606 | 0.18 | Why? |
| Community Networks | 2 | 2018 | 342 | 0.17 | Why? |
| Pattern Recognition, Automated | 1 | 2018 | 160 | 0.17 | Why? |
| Databases, Factual | 5 | 2021 | 6248 | 0.17 | Why? |
| Hospitalization | 7 | 2021 | 54280 | 0.17 | Why? |
| Drug Dosage Calculations | 1 | 2018 | 243 | 0.17 | Why? |
| Medical Informatics Computing | 1 | 2016 | 3 | 0.17 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.17 | Why? |
| Biostatistics | 1 | 2018 | 116 | 0.16 | Why? |
| Humanism | 1 | 2018 | 85 | 0.16 | Why? |
| Natural Language Processing | 1 | 2021 | 436 | 0.16 | Why? |
| Clinical Medicine | 1 | 2018 | 93 | 0.16 | Why? |
| Gene Ontology | 1 | 2018 | 391 | 0.16 | Why? |
| Product Surveillance, Postmarketing | 1 | 2018 | 189 | 0.15 | Why? |
| Models, Genetic | 1 | 2018 | 434 | 0.15 | Why? |
| Angioedema | 1 | 2017 | 111 | 0.15 | Why? |
| Regression Analysis | 3 | 2018 | 2484 | 0.15 | Why? |
| Antineoplastic Agents, Hormonal | 1 | 2017 | 203 | 0.14 | Why? |
| Aged, 80 and over | 11 | 2021 | 88759 | 0.13 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.13 | Why? |
| Age Distribution | 2 | 2021 | 3567 | 0.13 | Why? |
| Research | 2 | 2017 | 2115 | 0.13 | Why? |
| Death | 1 | 2017 | 334 | 0.13 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.13 | Why? |
| Genes | 1 | 2013 | 50 | 0.13 | Why? |
| United States | 9 | 2021 | 46150 | 0.13 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.13 | Why? |
| Androgen Antagonists | 1 | 2017 | 404 | 0.13 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.12 | Why? |
| Publications | 1 | 2018 | 463 | 0.12 | Why? |
| Information Storage and Retrieval | 1 | 2018 | 644 | 0.12 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| Bias | 1 | 2018 | 1109 | 0.12 | Why? |
| Prostatectomy | 1 | 2017 | 485 | 0.12 | Why? |
| Databases, Genetic | 1 | 2018 | 1127 | 0.11 | Why? |
| Humans | 32 | 2021 | 930598 | 0.11 | Why? |
| Health Services Research | 1 | 2017 | 756 | 0.11 | Why? |
| Coronary Disease | 1 | 2017 | 645 | 0.11 | Why? |
| California | 1 | 2017 | 2047 | 0.10 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.10 | Why? |
| United States Food and Drug Administration | 1 | 2017 | 1276 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Influenza, Human | 4 | 2021 | 10779 | 0.10 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.10 | Why? |
| Aged | 13 | 2021 | 215776 | 0.09 | Why? |
| Spain | 6 | 2021 | 15545 | 0.09 | Why? |
| Republic of Korea | 4 | 2021 | 5858 | 0.09 | Why? |
| Algorithms | 4 | 2018 | 7346 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
| Multiple Organ Failure | 1 | 2018 | 1724 | 0.09 | Why? |
| Adult | 12 | 2021 | 244371 | 0.08 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
| Male | 15 | 2021 | 367725 | 0.08 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.08 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Child | 6 | 2021 | 70012 | 0.08 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.08 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.07 | Why? |
| Female | 14 | 2021 | 380317 | 0.07 | Why? |
| Proteins | 1 | 2013 | 921 | 0.07 | Why? |
| Epilepsy | 1 | 2017 | 1401 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.07 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.06 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.06 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.06 | Why? |
| Artificial Intelligence | 1 | 2018 | 3543 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.06 | Why? |
| Administrative Claims, Healthcare | 1 | 2021 | 124 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.06 | Why? |
| Software | 1 | 2013 | 2501 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.05 | Why? |
| Myocardial Infarction | 1 | 2016 | 3361 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2019 | 4775 | 0.05 | Why? |
| Fluoroquinolones | 1 | 2021 | 235 | 0.05 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.05 | Why? |
| Propensity Score | 2 | 2018 | 2690 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Heart Failure | 2 | 2018 | 6638 | 0.05 | Why? |
| Ceftriaxone | 1 | 2021 | 365 | 0.05 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.05 | Why? |
| Mycoplasma pneumoniae | 1 | 2020 | 233 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.04 | Why? |
| Patient-Specific Modeling | 1 | 2018 | 60 | 0.04 | Why? |
| Codes of Ethics | 1 | 2018 | 50 | 0.04 | Why? |
| Physician-Patient Relations | 2 | 2018 | 1266 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Liver Failure, Acute | 1 | 2018 | 279 | 0.03 | Why? |
| Causality | 1 | 2018 | 857 | 0.03 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.03 | Why? |
| Inpatients | 2 | 2021 | 5161 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Brain Injuries | 1 | 2018 | 374 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Huntington Disease | 1 | 2013 | 47 | 0.03 | Why? |
| RNA Viruses | 1 | 2020 | 824 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2019 | 11304 | 0.03 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Ethics, Medical | 1 | 2018 | 533 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Protein Interaction Mapping | 1 | 2013 | 487 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Racism | 1 | 2018 | 1462 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Computer Simulation | 1 | 2018 | 4982 | 0.02 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Parkinson Disease | 1 | 2013 | 1414 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2018 | 3893 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2018 | 7301 | 0.01 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.01 | Why? |
| Internet | 1 | 2013 | 6204 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2019 | 25144 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
Shah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(169)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_